We are live on
!
Find out more
Eli Lilly
2,811 hedge funds and large institutions have $366B invested in Eli Lilly in 2023 Q2 according to their latest regulatory filings, with 297 funds opening new positions, 1,071 increasing their positions, 1,077 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1% less repeat investments, than reductions
Existing positions increased: 1,071 | Existing positions reduced: 1,077
8% less call options, than puts
Call options by funds: $3.39B | Put options by funds: $3.68B
5.84% less ownership
Funds ownership: 88.43% → 82.59% (-5.8%)
Holders
2,811
Holding in Top 10
242
Calls
$3.39B
Puts
$3.68B
Top Buyers
| 1 | +$1.35B | |
| 2 | +$701M | |
| 3 | +$603M | |
| 4 |
Barclays
London,
United Kingdom
|
+$380M |
| 5 |
Millennium Management
New York
|
+$342M |
Top Sellers
| 1 | -$22.2B | |
| 2 | -$2.46B | |
| 3 | -$764M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$746M |
| 5 |
Lilly Endowment
Indiananapolis,
Indiana
|
-$635M |